Both etanercept and infliximab can elevate tumor necrosis factor (TNF)-α and be the cause of treatment related new onset disease: The need to measure circulating TNF-α

Richard E. Kast; Eric L. Altschuler

Both etanercept and infliximab can elevate tumor necrosis factor (TNF)-α and be the cause of treatment related new onset disease: The need to measure circulating TNF-α

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	1679
Number of pages	1
Journal	Journal of Rheumatology
Volume	35
Issue number	8
State	Published - Aug 2008
Externally published	Yes

Cite this

@article{4247e1f497e540eab8b4fc14bdbc1cfb,

title = "Both etanercept and infliximab can elevate tumor necrosis factor (TNF)-α and be the cause of treatment related new onset disease: The need to measure circulating TNF-α",

author = "Kast, {Richard E.} and Altschuler, {Eric L.}",

year = "2008",

month = aug,

language = "English",

volume = "35",

pages = "1679",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "8",

}

TY - JOUR

T1 - Both etanercept and infliximab can elevate tumor necrosis factor (TNF)-α and be the cause of treatment related new onset disease

T2 - The need to measure circulating TNF-α

AU - Kast, Richard E.

AU - Altschuler, Eric L.

PY - 2008/8

Y1 - 2008/8

UR - http://www.scopus.com/inward/record.url?scp=49049098997&partnerID=8YFLogxK

M3 - Letter

C2 - 18671327

AN - SCOPUS:49049098997

VL - 35

SP - 1679

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 8

ER -